Literature DB >> 23445235

Management of giant liver hemangiomas: an update.

Lisette T Hoekstra1, Matthanja Bieze, Deha Erdogan, Joris J T H Roelofs, Ulrich H W Beuers, Thomas M van Gulik.   

Abstract

Liver hemangiomas are the most common benign liver tumors and are usually incidental findings. Liver hemangiomas are readily demonstrated by abdominal ultrasonography, computed tomography or magnetic resonance imaging. Giant liver hemangiomas are defined by a diameter larger than 5 cm. In patients with a giant liver hemangioma, observation is justified in the absence of symptoms. Surgical resection is indicated in patients with abdominal (mechanical) complaints or complications, or when diagnosis remains inconclusive. Enucleation is the preferred surgical method, according to existing literature and our own experience. Spontaneous or traumatic rupture of a giant hepatic hemangioma is rare, however, the mortality rate is high (36-39%). An uncommon complication of a giant hemangioma is disseminated intravascular coagulation (Kasabach-Merritt syndrome); intervention is then required. Herein, the authors provide a literature update of the current evidence concerning the management of giant hepatic hemangiomas. In addition, the authors assessed treatment strategies and outcomes in a series of patients with giant liver hemangiomas managed in our department.

Entities:  

Mesh:

Year:  2013        PMID: 23445235     DOI: 10.1586/egh.13.10

Source DB:  PubMed          Journal:  Expert Rev Gastroenterol Hepatol        ISSN: 1747-4124            Impact factor:   3.869


  34 in total

1.  Enucleation versus Anatomic Resection for Giant Hepatic Hemangioma: A Meta-Analysis.

Authors:  Yuhui Liu; Xuyong Wei; Kun Wang; Qiaonan Shan; Haojiang Dai; Haiyang Xie; Lin Zhou; Xiao Xu; Shusen Zheng
Journal:  Gastrointest Tumors       Date:  2017-02-11

2.  Management of Symptomatic Hepatic "Mega" Hemangioma.

Authors:  William A Ketchum; Kevin M Lin-Hurtubise; Emily Ochmanek; Kelli Ishihara; Robert D Rice
Journal:  Hawaii J Med Public Health       Date:  2019-04

3.  Hypergiant hepatic hemangiomas: case series.

Authors:  Devbrata R Adhikari; Vishal Thakur; Parag P Telavane; Rishabh Kulkarni; Rajinder Singh; Rajeev M Joshi
Journal:  Indian J Surg       Date:  2014-05-21       Impact factor: 0.656

4.  Orthotopic liver transplantation for giant liver haemangioma: A case report.

Authors:  Undine G Lange; Julian N Bucher; Markus B Schoenberg; Christian Benzing; Moritz Schmelzle; Tanja Gradistanac; Steffen Strocka; Hans-Michael Hau; Michael Bartels
Journal:  World J Transplant       Date:  2015-12-24

5.  Long-term outcomes of resection in patients with symptomatic benign liver tumours.

Authors:  Belle V van Rosmalen; Matthanja Bieze; Marc G H Besselink; Pieter Tanis; Joanne Verheij; Saffire S K S Phoa; Olivier Busch; Thomas M van Gulik
Journal:  HPB (Oxford)       Date:  2016-08-21       Impact factor: 3.647

6.  Laparoscopic vs computerized tomography-guided radiofrequency ablation for large hepatic hemangiomas abutting the diaphragm.

Authors:  Jun Gao; Jian Kong; Xue-Mei Ding; Shan Ke; Hai-Gang Niu; Zong-Hai Xin; Chun-Min Ning; Shi-Gang Guo; Xiao-Long Li; Long Zhang; Yong-Hong Dong; Wen-Bing Sun
Journal:  World J Gastroenterol       Date:  2015-05-21       Impact factor: 5.742

Review 7.  Benign liver tumours: understanding molecular physiology to adapt clinical management.

Authors:  Jean-Charles Nault; Valérie Paradis; Maxime Ronot; Jessica Zucman-Rossi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2022-07-14       Impact factor: 73.082

8.  Enucleation is Better for a Giant Hemangioma Proximal to the Hepatic Portal Vascular Structures.

Authors:  Chuan-Xing Wu; Wan-Yuan Bao; Feng Zhu
Journal:  Indian J Surg       Date:  2015-11-02       Impact factor: 0.656

9.  Revisiting the Surgical Management of Giant Hepatic Hemangiomas: Enucleation Versus Anatomical Resection?

Authors:  Muthukumarassamy Rajakannu; Gerard Pascal; Denis Castaing; Eric Vibert; Christian Ducerf; Jean-Yves Mabrut; Jacques Baulieux; René Adam
Journal:  J Clin Exp Hepatol       Date:  2020-10-02

10.  Comparison of two different biomaterials in the bone regeneration (15, 30 and 60 days) of critical defects in rats.

Authors:  Patricia Brassolatti; Paulo Sérgio Bossini; Ana Laura Martins de Andrade; Genoveva Lourdes Flores Luna; Juliana Virginio da Silva; Luciana Almeida-Lopes; Marcos Aurélio Napolitano; Lucimar Retto da Silva de Avó; Ângela Merice de Oliveira Leal; Fernanda de Freitas Anibal
Journal:  Acta Cir Bras       Date:  2021-07-19       Impact factor: 1.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.